To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
Find out MoreTIDM | RTW |
---|---|
Ticker Code | RTW.L |
ISIN | GG00BKTRRM22 |
Currency | USD |
Issue Country | GG |
Sector | - |
Year End | 31-Dec-23 |
Shares in Issue | 385.09m |
---|---|
Market Cap. | $504.46m |
Market Size | 3,000 |
PE Ratio | 3.638889 |
Earnings | 0.36 |
Dividend | 0.00 |
Yield | 0.00% |
# of Trades | 24 |
---|---|
Vol Sold | 87,823 |
Vol Bought | 4,182 |
52 Week High | 1.43 |
52 Week High Date | 31-Jan-2024 |
52 Week Low | 1.05 |
52 Week Low Date | 02-Nov-2023 |
Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
---|---|---|---|---|---|
Millions | Millions | Millions | Millions | Millions | |
Income Statement | 31 Dec '23 | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 |
Revenue | 4.17 | 2.17 | 0.66 | 0.15 | 0.08 |
Operating Profit / Loss | (3.20) | (4.51) | (7.80) | (4.88) | (1.28) |
Net Interest | (1.56) | (0.78) | n/a | (0.07) | (0.02) |
Pre Tax Profit | (4.76) | (5.29) | (7.80) | (4.95) | (1.30) |
Post Tax Profit | (4.76) | (5.29) | (7.80) | (4.95) | (1.30) |
Profit for the Period | (4.76) | (5.29) | (7.80) | (4.95) | (1.30) |
Equity Holders of Parent Company | (4.76) | (5.29) | (7.80) | (4.95) | (1.30) |
Minority Interests | n/a | n/a | n/a | n/a | n/a |
Continuing EPS | |||||
Earnings per Share (Basic) | (2.26USX) | (2.24USX) | (3.67USX) | (2.59USX) | (0.80USX) |
Earnings per Share (Diluted) | (2.26USX) | (2.24USX) | (3.67USX) | (2.59USX) | (0.80USX) |
Earnings per Share (Adjusted) | (2.26USX) | (2.24USX) | (3.67USX) | (2.59USX) | (0.80USX) |
Continuing and Discontinued EPS | |||||
Earnings per Share (Basic) | (2.26USX) | (2.24USX) | (3.67USX) | (2.59USX) | (0.80USX) |
Earnings per Share (Diluted) | (2.26USX) | (2.24USX) | (3.67USX) | (2.59USX) | (0.80USX) |
Earnings per Share (Adjusted) | (2.26USX) | (2.24USX) | (3.67USX) | (2.59USX) | (0.80USX) |
Dividend per Share | n/a | n/a | n/a | n/a | n/a |
Millions | Millions | Millions | Millions | Millions | |
Balance Sheet | 31 Dec '23 | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 |
Non-Current Assets | |||||
Intangible Assets | n/a | n/a | n/a | n/a | n/a |
Property, Plant and Equipment | n/a | n/a | n/a | n/a | n/a |
Investments | 367.61 | 350.13 | 409.18 | 390.79 | 170.65 |
Investment Properties | n/a | n/a | n/a | n/a | n/a |
Other Financial Assets | n/a | n/a | n/a | n/a | 0.00 |
Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
Total Non-Current Assets | 367.61 | 350.13 | 409.18 | 390.79 | 170.65 |
Current Assets | |||||
Inventories | n/a | n/a | n/a | n/a | n/a |
Trade and Other Receivables | n/a | n/a | n/a | n/a | n/a |
Cash at Bank and in Hand | 2.72 | 6.97 | 6.48 | 4.55 | 10.73 |
Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 2.72 | 6.97 | 6.48 | 4.55 | 10.73 |
Other Assets | 75.90 | 44.45 | 23.70 | 25.56 | 34.42 |
Total Assets | 446.23 | 401.54 | 439.36 | 420.90 | 215.80 |
Current Liabilities | |||||
Borrowings | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | n/a | 8.00 | 1.41 |
Total Current Liabilities | n/a | n/a | n/a | 8.00 | 1.41 |
Net Current Assets | n/a | n/a | n/a | n/a | n/a |
Non-Current Liabilities | |||||
Borrowings | n/a | n/a | n/a | n/a | n/a |
Provisions | n/a | n/a | n/a | n/a | n/a |
Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
Total Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
Net Assets | 429.02 | 347.92 | 387.36 | 412.61 | 214.00 |
Capital and Reserves | |||||
Share Capital | n/a | n/a | n/a | n/a | n/a |
Share Premium Account | n/a | n/a | n/a | n/a | n/a |
Other Reserves | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | n/a | n/a | n/a | n/a | n/a |
Shareholders Funds | 429.02 | 347.92 | 387.36 | 412.61 | 214.39 |
Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
Total Equity | 429.02 | 347.92 | 387.36 | 412.61 | 214.00 |
31 Dec '23 | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 | |
Operating Margin | (76.80%) | (208.16%) | (1,185.49%) | (3,166.32%) | (1,600.00%) |
Return on Capital Employed | n/a | n/a | n/a | n/a | n/a |
Dividend Cover | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
PE Ratio | n/a | n/a | n/a | n/a | n/a |
PEG | n/a | n/a | n/a | n/a | n/a |
Dividend per Share Growth | n/a | n/a | n/a | n/a | n/a |
Net Asset Value per Share | $1.11 | $0.90 | $1.00 | $1.07 | $0.55 |